Document is current
Any future updates will be listed below
-
Authors
Sillero-Rejon, Carlos https://orcid.org/0000-0001-5502-9247
Hollingworth, William
Opmeer, Brent C.
Luyt, Karen
McLeod, Hugh
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR200181)
- License Information
-
More Information
Article History
Accepted: 27 July 2025
First Online: 12 August 2025
Declarations
:
: The authors declare no competing interests.
: The PReCePT Study—a cluster randomised trial evaluating the impact of an enhanced support implementation of the PReCePT quality improvement toolkit to increase the uptake of magnesium sulphate in preterm deliveries for the prevention of neurodisabilities was granted a favourable ethical opinion by the National Research Ethics Service (REC ref: 19/HRA/0323). The PReCePT Programme Evaluation was granted a favourable ethical opinion by the UK National Health Service Health Research Authority (HRA project ID: 260504) and the University of Bristol Faculty of Health Sciences Research Ethics Committee (FREC ref: 84582).
: Not applicable.
: Not applicable.
: Anonymised individual-level data for this study are from the UK National Neonatal Research Database (NNRD). Our data sharing agreement with the NNRD prohibits sharing data extracts outside of the University of Bristol research team. The NNRD data dictionary is available online, and copies of the statistical analysis plan are available in the University of Bristol’s institutional repository (-). Analysis code can be made available upon inquiry to the corresponding author.
: C.S.R., W.H., B.O. and H.M. led the health economic design and analysis plans, with contributions from K.L. C.S.R., W.H. and H.M. performed the health economic analysis and interpretation. C.S.R. wrote the original manuscript. All authors (C.S.R., W.H., B.O., K.L. and H.M.) reviewed the manuscript and approved the submission. K.L. was the chief investigator and guarantor of PReCePT studies.
